MedTrace Logo

Patient Satisfaction and Pain Control Following Reconstructive Vaginal Surgery

NCT01442818 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2015-07-10

No results posted yet for this study

Summary

The investigators hypothesize that patient controlled analgesia (PCA) provides superior pain relief and patient satisfaction when compared to scheduled intravenous analgesia following vaginal reconstructive surgery.

Conditions

  • Post Operative Pain

Interventions

DRUG

Dilaudid PCA

PCA setting of 0.3mg demand dose, 8 minute lock out interval, and 5mg 4-hour limit.

DRUG

Dilaudid IV Scheduled

Nurse administered IV Dilaudid 0.5mg every 2 hours.

Sponsors & Collaborators

  • TriHealth Inc.

    lead OTHER

Principal Investigators

  • Catrina C Crisp, MD · TriHealth Division of Urogynecology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-09-30
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01442818 on ClinicalTrials.gov